CRISPR/Cas9 technology generated a leucine to alanine substitution at amino acid 1085 (L1085A). This mutation abolishes the binding activity of Nbea for the catalytic subunit of protein kinase A. (J:82809)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count